3 completed. 3 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
| Phase 2 | 1 | Completed 1 |
Follow Measles: new trials by email Literature Review of Measles trials Research Report on Measles
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Measles and Rubella Vaccine Microneedle Patch Phase 1-2 Age De-escalation Trial Measles Rubella Vaccine (MRV-SC), MRV-MNP, PLA-MNP - Measles, Rubella | Phase 1 / Phase 2 | Completed | Micron Biomedical, Inc | 281 | 2021-05-19 | 2023-03-29 |
| Phase I Trial of Measles Vectored Chikungungya Vaccine Placebo, VRC-CHKVLP059-00-VP - Chikungunya Virus Infection | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 180 | 2017-05-30 | 2020-11-27 |
| Study to Evaluate Safety and Imunogenicity of Double Viral Vaccine (MR) for Measles and Rubella Double viral (MR) vaccine - Rubella, Measles | Phase 1 | Completed | The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) | 30 | 2015-09-01 | 2016-06-22 |
Rubella (2) · Chikungunya Fever (1)
Infections (3) · Mononegavirales Infections (3) · Morbillivirus Infections (3) · Paramyxoviridae Infections (3) · RNA Virus Infections (3) · Togaviridae Infections (3) · Virus Diseases (3) · Rubivirus Infections (2) · Alphavirus Infections (1) · Arbovirus Infections (1) · Mosquito-Borne Diseases (1) · Vector Borne Diseases (1)
Measles Vaccine (1) · Rubella Vaccine (1) · Vaccines (1)
Micron Biomedical, Inc (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz) (1)
Brazil (1) · The Gambia (1) · United States (1)
Ed Clarke, MD (1) · Jose CerbinoNeto, PHD (1)